<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08033638953143</udiDi>
    <basicUdiDi>803363895TO001BL</basicUdiDi>
    <tradeName>IALUSET HL</tradeName>
    <deviceName>HA cream for Dressings</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M040499</emdnCode>
    <emdnDescription>DRESSINGS FOR WOUNDS, SORES AND ULCERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638953143</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:08:48.531Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638951187</udiDi>
    <basicUdiDi>803363895CO0015R</basicUdiDi>
    <tradeName>KAROS GOLA PASTIGLIE</tradeName>
    <deviceName>Orodispersible Tablets HA + Carbomer + Xanthan Gum</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0399</emdnCode>
    <emdnDescription>ENT DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638951187</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:08:47.724Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638950029</udiDi>
    <basicUdiDi>803363895RE0018Q</basicUdiDi>
    <tradeName>ALIAMARE</tradeName>
    <deviceName>Rhinological and otological solution sea water and HA 0,2%</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0399</emdnCode>
    <emdnDescription>ENT DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638950029</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:08:43.719Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689863543</udiDi>
    <basicUdiDi>803363895ID0035J</basicUdiDi>
    <tradeName>Perovial</tradeName>
    <deviceName>Hyaluronic Acid Sodium Salt for intralesional Penile Injection</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689863543</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:55.626Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689863536</udiDi>
    <basicUdiDi>803363895ID0035J</basicUdiDi>
    <tradeName>Perovial</tradeName>
    <deviceName>Hyaluronic Acid Sodium Salt for intralesional Penile Injection</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689863536</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:54.425Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860191</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860191</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:53.234Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860184</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860184</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:47.324Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860177</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860177</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:44.819Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860160</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860160</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:43.613Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860153</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860153</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:42.424Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860146</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860146</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:36.416Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689860139</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689860139</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:54:35.230Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638958100</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638958100</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:39:14.120Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638956021</udiDi>
    <basicUdiDi>803363895IA0024T</basicUdiDi>
    <tradeName>SINOGEL</tradeName>
    <deviceName>SODIUM HYALURONATE 2.4% and SODIUM CHONDROITIN 1.6% - VISCO-SUPPLETIVE JOINT DEVICE</deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638956021</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:39:12.912Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638950807</udiDi>
    <basicUdiDi>803363895RE0018Q</basicUdiDi>
    <tradeName>ALIAMARE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0399</emdnCode>
    <emdnDescription>ENT DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638950807</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.729Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638950814</udiDi>
    <basicUdiDi>803363895RE0018Q</basicUdiDi>
    <tradeName>ALIAMARE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0399</emdnCode>
    <emdnDescription>ENT DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638950814</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.708Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638954508</udiDi>
    <basicUdiDi>803363895TO001BL</basicUdiDi>
    <tradeName>IALUSET</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M040499</emdnCode>
    <emdnDescription>DRESSINGS FOR WOUNDS, SORES AND ULCERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638954508</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638955123</udiDi>
    <basicUdiDi>803363895TO001BL</basicUdiDi>
    <tradeName>IALUSET</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M040499</emdnCode>
    <emdnDescription>DRESSINGS FOR WOUNDS, SORES AND ULCERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638955123</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.605Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033638958544</udiDi>
    <basicUdiDi>803363895RE0018Q</basicUdiDi>
    <tradeName>ALIAMARE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0399</emdnCode>
    <emdnDescription>ENT DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8033638958544</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.547Z</lastUpdated>
  </row>
  <row>
    <udiDi>08053689863161</udiDi>
    <basicUdiDi>803363895TO001BL</basicUdiDi>
    <tradeName>IALUSET</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IBSA FARMACEUTICI ITALIA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000008111</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M040499</emdnCode>
    <emdnDescription>DRESSINGS FOR WOUNDS, SORES AND ULCERATIONS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8053689863161</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:24:23.477Z</lastUpdated>
  </row>
</eudamedExport>